Identical twins may have more differences than meet the eye

July 07, 2005

COLUMBUS , Ohio - Identical twins lose some fundamental similarities as they grow older, a new study reports.

They may start to look and act less alike. The changes could leave one twin susceptible to diseases like cancer, while the other twin remains healthy.

Researchers report in this week's Proceedings of the National Academy of Sciences that these differences may stem from changes in the epigenome. The epigenome refers to chemical modifications in genes that don't directly affect a gene's DNA but result in changes in gene expression.

Scientists think that chemical exposure, dietary habits and environmental factors may all have epigenetic affects.

Most epigenetic changes are normal and may explain why pairs of twins lose some of their identical attributes as they age. But learning how these modifications affect cells may also shed light on how cancer progresses and develops, said Christoph Plass, a study co-author and an associate professor of molecular virology, immunology and medical genetics at Ohio State University .

Plass and Yue-Zhong Wu, a research associate also at Ohio State , helped a team of European scientists analyze epigenetic changes in twins' genomes. The group was led by Manel Esteller, a researcher with the Spanish National Cancer Center in Madrid .

The researchers studied 40 pairs of twins recruited in Spain , Denmark and the United Kingdom ; 25 of the pairs were female. The youngest set of twins was 3, and the oldest pair was 74. All of the participants were asked to complete questionnaires about their health, eating habits, physical activity, history of prescription medication use and tobacco, alcohol and drug consumption.

The researchers also drew blood samples from each participant in order to analyze and compare similarities and differences in the epigenome.

Results from the blood tests - and from the questionnaires - showed that the youngest set of twins had the most identical genomes. But that wasn't true for the oldest pairs of twins. Genetically speaking, these twins were the least alike.

The process that alters gene expression and behavior without changing a gene's DNA sequence is called methylation. Plass, who is also part of the human cancer genetics program at Ohio State, studies methylation in both normal and cancer cells in hopes of better understanding how the process affects the beginning and progression of the disease.

"Methylation is important for normal cellular development," Plass said. "It can help protect the integrity of a DNA sequence. But certain changes in the regulation of DNA methylation could have fatal consequences for a cell or individual."

Identical twins are born with an identical set of genes. Studying genetic differences in twins may give Plass and his colleagues insight into how methylation is regulated.

"One would expect identical twins to develop and express genes at the same levels, but in fact this changes over time," Plass said. "We think that methylation plays a genome-wide role in these changes."

Scientists think that foods, exposure to chemicals, physical activity levels and aging may all contribute to methylation in cells. But they don't understand how changes in DNA methylation occur, or how the process is regulated.

The DNA analysis in this study showed that twins who had spent less of their lives together, or had greater differences in their health and medical histories, had the greatest amount of methylation.

The next step for Plass is to compare the findings of this study to what he sees in cancer cell cultures in his laboratory.

"Nearly every tumor, every human malignancy shows changes in DNA methylation that mess up gene expression," he said. "If we understand what regulates methylation patterns, then we may be able to develop better treatment options for cancer."

The researchers received financial support for this work from the Foundation of the Spanish Association Against Cancer.

Plass, Yu and Esteller conducted the study with researchers from Spain, Sweden, Denmark and the United Kingdom.
-end-
Contact: Christoph Plass, 614-292-6505; plass-1@medctr.osu.edu

Written by Holly Wagner, 614-292-8310; Wagner.235@osu.edu

Ohio State University

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.